Personalized Hygiene Care Tailoring Products to Individual Needs

Personalized Hygiene Care Tailoring Products to Individual Needs

Dr. P Sreelatha, Founder, Feminy Enterprises

In an interaction with India Pharma Outlook, Dr. P Sreelatha, Founder of  Feminy Enterprises, discusses how India's hygiene product market is growing with innovation and increased affordability, but rural areas face challenges like low awareness and access. Furthermore, she is stating how South Indian biodegradable pad manufacturer addresses this gap through community outreach, regulatory compliance, and cost-effective production, while leveraging B2C platforms and user feedback to offer personalized, safe solutions.

As demand grows for microbiome-safe and skin-type-specific hygiene products, how are Indian brands rethinking personalization across formulation, packaging, and user engagement strategies?

The market for hygiene products is increasing, and the affordability among the population, particularly the middle and upper-middle classes, has also improved. Even individuals from lower-income backgrounds are now able to afford hygiene products and have started recognizing the importance of good quality. As a result, the market is undoubtedly growing.

For example, in 2017, the compound annual growth rate (CAGR) was 8.2%, and the market value exceeded 3,700 million dollars. It is now estimated to reach approximately 5,700 million dollars by 2027, with the CAGR projected to increase to 8.8% between 2022 and 2027. This clearly reflects a positive growth trajectory in the hygiene market. However, despite this growth, the market continues to face significant challenges. In rural and interior areas, awareness about hygiene products remains limited. Many individuals are still not well-informed about menstrual hygiene and related health issues. In these regions, higher rates of childbirth complications, PCOD (Polycystic Ovarian Disease), and abortions are observed, with poor menstrual hygiene being one of the contributing factors. Traditional practices, such as the use of cloth during menstruation, are still prevalent in these areas.

From the perspective of NGOs working in rural regions, such traditional practices and lack of awareness are commonly observed. While middle-class and upper-middle-class populations can afford hygiene products, affordability remains a major issue for lower-middle-class and labor-class populations, in fact representing a larger percentage of the population.

On the development front, the market is also witnessing numerous innovations. These include customized sizes, new materials, diverse shapes, and the introduction of skin-friendly, organic, compostable, and environmentally friendly products. Many of these products are designed to enhance comfort and suitability for women. However, such innovations are more prominent in urban areas, where higher-income groups have better access to and affordability for these advanced products.

In conclusion, while the hygiene product market is growing and experiencing innovation, the pace of this growth remains relatively low due to the challenges in rural penetration, affordability issues for economically weaker sections, and lack of awareness.

How is Indian brands using dermatological data, regional climate insights, and user feedback to customize hygiene solutions for diverse consumer segments across geographies?

Drawing from personal experience as a manufacturer, the founder shared the challenges faced in establishing a biodegradable sanitary napkin production company in South India. This was the first company of its kind in the region. While many had attempted to start similar ventures and eventually gave up, this entrepreneur persisted, despite numerous obstacles, particularly because the company was set up in a rural area.

With a background in NGO work and a strong social commitment, the founder was driven by a vision to ensure that menstrual hygiene products reached everyone, especially those in rural communities. The motivation stemmed from witnessing various community health issues, many of which were preventable with improved hygiene practices.

By what the founder describes as "God’s grace," the opportunity arose to establish a company that catered to a wide spectrum of society, from laborers and lower-income individuals to middle-class and elite consumers. However, the journey was far from easy. Marketing the product posed a significant challenge. Even among adolescent girls and young, educated women, awareness about menstrual hygiene and related health issues was found to be lacking.

To address this, the company simultaneously launched awareness initiatives in rural areas through Community-Based Organizations (CBOs). These efforts were implemented in collaboration with ASHA workers, Anganwadi teachers, nurses, and Auxiliary Nurse Midwives (ANMs). Awareness programs were also introduced in schools, with a dual focus on menstrual hygiene education and women empowerment. The aim was to make the sessions engaging and impactful for children, adolescent girls, and young women.

What began at the village level gradually expanded to the district level. These efforts, over time, helped create awareness and generate interest among communities, ultimately contributing to the gradual success and reach of the company.

Also Read: How CDMOs Are Driving Agility and Innovation in the Pharmaceutical Supply Chain

What role do B2C platforms and digital skin assessments play in scaling personalized hygiene offerings without compromising product safety or shelf-life stability?

In the B2B space, many multinational companies already dominate with large advertisements, digital campaigns, and social media outreach. However, these efforts often fail to reach rural areas and lower-income communities, where a significant portion of the population resides.

Unlike B2B, B2C platforms allow for direct interaction with customers. While this approach may take longer to show results, it offers the opportunity to truly connect with rural and interior regions. The focus of this initiative is on reaching and serving rural India.

To achieve this, a unique set of strategies is being employed, and different from those used for urban or more affluent populations. The team is leveraging the support of community-based organizations such as self-help groups, local ASHA workers, and NGOs. NGOs, in particular, play a crucial role due to their deep-rooted presence and credibility within these communities.

While the process of penetrating the rural mindset is slow and challenging, it is considered a worthwhile endeavor. The team acknowledges that creating meaningful engagement and lasting impact in rural India takes time, but they are committed to facing this challenge head-on.

How are personal care brands navigating regulatory clarity around customized formulations, ingredient transparency, and data protection in personalized hygiene solutions?

To enter the market, it is essential for the company to adhere to all relevant regulations and standards. This includes compliance with BIS (Bureau of Indian Standards) as well as the guidelines set by the Ministry of Health and Family Welfare. The company acknowledges that it is not only competing with itself but also with large, well-established players in the market. Although it considers itself a small player, a mere "drop" in comparison, it still strives to meet all regulatory requirements.

Regarding raw materials, especially since the company manufactures biodegradable sanitary pads, it ensures that vendors provide proof of biodegradability. Vendors are asked to submit test results for the raw materials they supply. If the materials are genuinely biodegradable, the vendors are expected to have conducted proper testing and are able to provide certified results. The company collects and reviews these documents to verify compliance.

However, the company does not have its own advanced biodegradability testing facilities due to the high cost involved. As it also works to support low-income communities, it aims to keep its processes cost-effective. Instead, it conducts its own basic in-house testing, placing materials in soil to observe the decomposition process and track how long it takes to degrade. Based on these observations, the company selects appropriate materials.

In terms of quality and hygiene, the company ensures that strict inspection and monitoring are carried out throughout the entire manufacturing process, from production to packaging. It follows stringent hygienic manufacturing practices and maintains a close check on compliance at every stage.

on the deck

Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest

Related Articles


© 2025 India Pharma Outlook. All Rights Reserved.